Allarity Therapeutics (ALLR) Competitors $0.98 -0.01 (-1.10%) Closing price 04:00 PM EasternExtended Trading$0.96 -0.01 (-1.44%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALLR vs. GNTA, SNTI, ANL, ZIVO, MGX, VRCA, KRON, HOWL, IFRX, and DTILShould you be buying Allarity Therapeutics stock or one of its competitors? The main competitors of Allarity Therapeutics include Genenta Science (GNTA), Senti Biosciences (SNTI), Adlai Nortye (ANL), ZIVO Bioscience (ZIVO), Metagenomi (MGX), Verrica Pharmaceuticals (VRCA), Kronos Bio (KRON), Werewolf Therapeutics (HOWL), InflaRx (IFRX), and Precision BioSciences (DTIL). These companies are all part of the "pharmaceutical products" industry. Allarity Therapeutics vs. Its Competitors Genenta Science Senti Biosciences Adlai Nortye ZIVO Bioscience Metagenomi Verrica Pharmaceuticals Kronos Bio Werewolf Therapeutics InflaRx Precision BioSciences Genenta Science (NASDAQ:GNTA) and Allarity Therapeutics (NASDAQ:ALLR) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, risk, valuation, profitability and analyst recommendations. Do analysts rate GNTA or ALLR? Genenta Science currently has a consensus target price of $25.00, indicating a potential upside of 720.75%. Given Genenta Science's stronger consensus rating and higher probable upside, equities analysts clearly believe Genenta Science is more favorable than Allarity Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Genenta Science 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Allarity Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media refer more to GNTA or ALLR? In the previous week, Genenta Science and Genenta Science both had 1 articles in the media. Allarity Therapeutics' average media sentiment score of 1.87 beat Genenta Science's score of 1.44 indicating that Allarity Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment Genenta Science Positive Allarity Therapeutics Very Positive Do institutionals & insiders have more ownership in GNTA or ALLR? 15.1% of Genenta Science shares are owned by institutional investors. Comparatively, 11.5% of Allarity Therapeutics shares are owned by institutional investors. 29.0% of Genenta Science shares are owned by company insiders. Comparatively, 0.1% of Allarity Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has better earnings & valuation, GNTA or ALLR? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGenenta ScienceN/AN/A-$9.64MN/AN/AAllarity TherapeuticsN/AN/A-$24.51MN/AN/A Which has more risk & volatility, GNTA or ALLR? Genenta Science has a beta of 0.73, suggesting that its share price is 27% less volatile than the S&P 500. Comparatively, Allarity Therapeutics has a beta of -0.15, suggesting that its share price is 115% less volatile than the S&P 500. Is GNTA or ALLR more profitable? Genenta Science's return on equity of 0.00% beat Allarity Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Genenta ScienceN/A N/A N/A Allarity Therapeutics N/A -147.94%-90.33% SummaryGenenta Science beats Allarity Therapeutics on 9 of the 10 factors compared between the two stocks. Get Allarity Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ALLR and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALLR vs. The Competition Export to ExcelMetricAllarity TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.93M$2.84B$5.42B$8.78BDividend YieldN/A2.71%5.37%4.22%P/E RatioN/A21.0425.5519.55Price / SalesN/A291.35393.33108.03Price / CashN/A43.1936.0256.31Price / Book0.607.197.865.50Net Income-$24.51M-$55.15M$3.15B$248.79M7 Day Performance12.35%1.31%1.27%2.15%1 Month Performance-4.94%8.20%5.50%5.82%1 Year Performance-83.76%0.52%39.41%18.22% Allarity Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALLRAllarity Therapeutics1.1326 of 5 stars$0.98-1.1%N/A-84.1%$14.93MN/A0.0010Positive NewsGNTAGenenta Science3.0663 of 5 stars$3.06flat$25.00+717.0%-7.2%$55.97MN/A0.007Positive NewsSNTISenti Biosciences2.8844 of 5 stars$1.99-6.6%$8.50+327.1%-27.3%$55.55M$2.56M-0.184Positive NewsANLAdlai Nortye1.6277 of 5 stars$1.40-4.8%$9.00+542.8%-50.5%$54.24M$5M0.00127Positive NewsGap DownZIVOZIVO Bioscience0.2722 of 5 stars$14.22flatN/A+88.7%$54.22M$15.85K-2.9110News CoverageGap UpMGXMetagenomi2.9279 of 5 stars$1.42-2.1%$13.00+815.5%-58.2%$54.20M$45.26M-0.67236VRCAVerrica Pharmaceuticals4.1903 of 5 stars$0.59+0.4%$8.00+1,262.2%-91.5%$54.09M$7.57M-0.4940KRONKronos Bio3.2727 of 5 stars$0.88+1.5%$1.63+84.7%-6.9%$53.72M$9.85M-0.82100HOWLWerewolf Therapeutics3.7456 of 5 stars$1.25+5.0%$8.33+566.7%-48.9%$53.40M$1.88M-0.7540Positive NewsIFRXInflaRx2.54 of 5 stars$0.79-0.3%$6.60+732.3%-48.1%$53.38M$180K-0.9760Gap DownDTILPrecision BioSciences4.312 of 5 stars$4.53-5.4%$47.00+937.5%-55.7%$53.11M$68.70M-2.25200News Coverage Related Companies and Tools Related Companies Genenta Science Alternatives Senti Biosciences Alternatives Adlai Nortye Alternatives ZIVO Bioscience Alternatives Metagenomi Alternatives Verrica Pharmaceuticals Alternatives Kronos Bio Alternatives Werewolf Therapeutics Alternatives InflaRx Alternatives Precision BioSciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ALLR) was last updated on 6/26/2025 by MarketBeat.com Staff From Our PartnersThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredWhy July is critical for your stocksBig Study Shows Stocks Extremely Likely to Crash in 2026? Legendary quant analyst Marc Chaikin says in 50 y...Chaikin Analytics | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump Knows Exactly What He’s Doing…With Trump in office, new money is flowing in and out of the market like never before... And some folks usi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allarity Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allarity Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ALLR Stock Free ALLR Stock Alerts